Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical effects and biomarkers of biological agents on asthma
jRCT1031190033Completed
- Sponsor
- National Hospital Organization
- Start
- Jul 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of omalizumab, mepolizumab and benralizumab in asthma, sponsored by National Hospital Organization. Primary endpoint: Asthma Control Questionnaire (ACQ). Started Jul 2019; status: completed.
02
Drugs
omalizumabmepolizumabbenralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT1031190033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031190033.